1.Clinical effects of partial rectus muscle transportation procedure for paralytic strabismus
Xiao-Ying, WU ; Jie-Yue, WANG ; Feng-Yun, LI
International Eye Science 2016;16(8):1596-1598
Abstract?AIM: To analyze the clinical effects of partial rectus muscle transportation procedure for paralytic strabismus due to single rectus muscle paralysis.?METHODS:The conditions of 22 patients (25 eyes) who underwent partial rectus muscle transportation procedure for paralytic strabismus due to single rectus muscle paralysis were retrospectively reviewed. The following data were analyzed:1 ) the angle of deviation of primary position; 2 ) the presence of diploma in the primary position;3) the presence of compensatory head posture;4) the motility of the affected eye.All of the patients attended 6mo postoperative follow-up examinations.?RESULTS: According to the results of examinations before and during operation, different operations were performed:2 eyes were treated with partial rectus muscle transportation, 20 eyes were treated with recession of antagonistic muscle of paralytic rectus muscle combined with partial rectus muscle transportation, 3 eyes were treated with recession of antagonistic muscle, partial rectus muscle transportation and recession of yoke muscle.Twenty patients were orthotropia in the primary position, the diploma and abnormal head posture were eliminated. Two patients with binocular lateral rectus muscles paralysis were in mild undercorrection which were resolved by wearing 8△and 10△prisms respectively. The procedure improved strabismus of 25 eyes from 100.23△ ± 42.61△ preoperatively to 0.82△ ± 2.67△postoperatively ( t=10.797,P<0.001).Ocular movement was improved from -4.52 ±0.51 preoperatively to -2.68 ± 0.63 postoperatively (t=-19.468, P<0.001).? CONCLUSION: Partial rectus muscle transportation procedure for paralytic strabismus due to single rectus muscle paralysis can effectively correct the primary position in paralytic strabismus, eliminate the presence of diploma in primary position and abnormal head posture, and improve the ocular motility, which provides content clinical effects.
2.EGFR gene detection using transbronchial lung biopsy specimens.
Yun-en LIN ; Ping HE ; Shi-yue LI ; Ying-ying GU ; Miao-li YU
Chinese Journal of Pathology 2011;40(2):111-112
Adenocarcinoma
;
genetics
;
pathology
;
surgery
;
Adult
;
Aged
;
Aged, 80 and over
;
Biopsy
;
methods
;
Bronchoscopy
;
Carcinoma, Large Cell
;
genetics
;
pathology
;
surgery
;
Carcinoma, Non-Small-Cell Lung
;
genetics
;
pathology
;
surgery
;
Carcinoma, Squamous Cell
;
genetics
;
pathology
;
surgery
;
Female
;
Gene Amplification
;
Humans
;
Lung Neoplasms
;
genetics
;
pathology
;
surgery
;
Male
;
Middle Aged
;
Polyploidy
;
Receptor, Epidermal Growth Factor
;
genetics
;
Young Adult
3.Effect of Administration of Lactobacittus casei Zhang on Serum Lipids and Fecal Steroids in Hypercholesterolemic Rats
Yue-Ying YUN ; Li-Ping WANG ; He-Ping ZHANG ; Yong-Fu CHEN ; Mehe BILIGE ;
Microbiology 1992;0(03):-
Cholesterol-degrading strains was isolated from traditional koumiss. The effects of Lb. casei Zhang on the total serum cholesterol (TC) , triglycerid (TG), high density liporotein-cholesterol (HDL-C) low density liporotein-cholesterol (LDL-C) were investigated in artificially-induced hyperlipemial rats. The results showed that only heat-killed cells of Lb. casei Zhang significantly reduced serum TC (P
4.Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes / myoclonus epilepsy with ragged-red fibers /Leigh overlap syndrome caused by mitochondrial DNA 8344A>G mutation.
Yue HOU ; Xu Tong ZHAO ; Zhi Ying XIE ; Yun YUAN ; Zhao Xia WANG
Journal of Peking University(Health Sciences) 2020;52(5):851-855
OBJECTIVE:
Mitochondrial deoxyribonucleic acid (mtDNA) 8344 A>G (m.8344A>G) mutation is the common mutation associated with mitochondrial myoclonus epilepsy with ragged-red fibers (MERRF) syndrome. Herein we report a rare case with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes/MERRF/Leigh (MELAS/MERRF/Leigh) overlap syndrome caused by m.8344A>G mutation.
METHODS:
The clinical and imaging data of the patient were collected and an open muscle biopsy was carried out. We further employed molecular genetic analyses to detect mtDNA mutation in the proband and his mother. And then a clinical and neuroimaging follow-up was performed.
RESULTS:
This patient was a 25-year-old male, who developed exercise intolerance since the age of 6. At age 10, he suffered from acute episodes of hemianopia, and cranial magnetic resonance imaging (MRI) showed occipital stroke-like lesions and cranial magnetic resonance spectroscopy (MRS) revealed a lactate peak corresponding to the lesion. After that the patient presented slowly progressive psychomotor decline. He had myoclonic seizures and cerebellar ataxia since the age of 12. At age 21, he was admitted to our hospital because of confusion and cranial MRI revealed symmetrical lesions in bilateral posterior putamen, thalami and midbrain. Then repeated MRI showed progression of original lesions and new frontal multiple stroke-like lesions. Symptomatic and rehabilitation treatment relieved his condition. Follow-up cranial MRI at age 24 showed the lesions in basal ganglia and thalami diminished, and the midbrain lesions even completely vanished. Muscle pathology indicated the presence of numerous scattered ragged-red fibers (RRF), suggestive of a mitochondrial disorder. Polymerase chain reaction-restricted fragment length polymorphism (PCR-RFLP) detected the m.8344A>G mutation of the MT-TK gene encoding mitochondrial transfer RNA for lysine in the patient's blood. Next generation sequencing (NGS) of the whole mitochondrial genome identified that the proportion of m.8344A>G was 90%, and no other mtDNA mutation was detected. Sanger sequencing further identified this mutation both in the proband and his mother's blood, although the mutation load was much lower in his mother's blood with approximately 10% heteroplasmy.
CONCLUSION
The present study is the first to describe a patient with m.8344A>G mutation in association with the MELAS/MERRF/Leigh overlap syndrome, which expands the phenotypic spectrum of the m.8344A>G mutation.
Acidosis, Lactic
;
Adult
;
Child
;
DNA, Mitochondrial/genetics*
;
Humans
;
Male
;
Mitochondrial Encephalomyopathies
;
Mutation
;
Stroke
;
Young Adult
5.Mechanism of Schisandra Chinensis -mediated microglia phenotypic transformation by regulation of the TLR4 pathway based on miR-124
Yun-fang YANG ; Yue ZHANG ; Jing PENG ; Bo WU ; Ying JIA ; Ting-xu YAN
Acta Pharmaceutica Sinica 2023;58(2):377-385
To investigate the mechanism by which
6.Physiological pharmacokinetic model of children and its application of modeling software
Xu ZHOU ; Yuan-yuan WEI ; Tao MA ; Yue-zhou TANG ; Yun-jie DANG ; De-ying CAO
Acta Pharmaceutica Sinica 2023;58(2):320-329
Developmental changes in children can affect drug disposition and clinical effects. A physiologically-based pharmacokinetic (PBPK) model is a mathematical model that can be used to predict blood drug concentrations in children and gain insight into age-dependent physiological differences in drug disposition impact. Pediatric PBPK (P-PBPK) models have attracted attention over the past decade. With the concerted efforts of academia, pharmaceutical companies, and regulatory agencies, there are more and more examples of pediatric clinical studies using PBPK models. Nevertheless, the number of P-PBPK models and their predictive performance still lag behind adult models. By referring to the literature, we study the process of children adapting to adult absorption, distribution, metabolism, and excretion (ADME) parameters and analyze the general principles of P-PBPK model establishment. In addition, we summarize the functions and application examples of commonly used P-PBPK modeling software to provide a basis for the rational application of modeling software.
7.Analysis of the Epidemic Tendency of Methicillin-Resistant Staphylococcus aureus at a Hospital
Chen LI ; Yun-ying DONG ; Yue-zhu MA ; Shuqing ZHOU ; Hui CHEN ; Haiqing ZHANG
Chinese Journal of Rehabilitation Theory and Practice 2006;12(3):261-262
ObjectiveTo analysis the epidemic tendency of the methicillin-resistant Staphylococcus aureus(MRSA).MethodsClinical data of patients from August 2004 to August 2005 were analyzed retrospectively.Results62 Staphylococcus aureus were isolated,and the MRSA isolated rate was 59%.The MRSA patients tended to complex infection.ConclusionThe infection caused by MRSA is serious.It is necessary to take effective measures to control the MRSA prevalence.
8.Epilepsy in Alzheimer's disease: a retrospective study
Xun LI ; Shuai LIU ; Yun YANG ; Ying ZHANG ; Yong JI ; Wei YUE
Chinese Journal of Geriatrics 2021;40(2):163-167
Objective:To analyze the prevalence of epilepsy and its clinical features in patients with Alzheimer's disease(AD).Methods:Clinical data of patients with AD from a separate database of Tianjin Huanhu Hospital for dementia and degenerative diseases from January 2010 to January 2019 were retrospectively examined.The prevalence of AD combined with epilepsy was analyzed.The characteristics from neuropsychological assessment, clinical manifestations of epileptic attacks, electroencephalogic patterns and other features were analyzed and compared with those of AD patients without epilepsy.Results:Of 376 AD patients, 11.4% had epilepsy, with 4.0% showing non-induced seizures before AD diagnosis and 7.5% after AD diagnosis.The average age of AD patients at first onset of epilepsy was 59.8±19.9 years, and the average age of patients at initial diagnosis with AD was 62.8±6.6 years.The most common type was focal seizures(65.1%), and EEG showed mostly focal slow waves(69.8%)and focal epileptiform discharges(23.3%). The AD diagnosis for patients with epilepsy was 8 years earlier than those without epilepsy.Conclusions:Epilepsy has a high prevalence in AD patients, and seizures may be a risk factor for progression from cognitive impairment to AD.Early identification of seizures and cognitive impairment may have a positive effect on delaying the progression of dementia.
9.Design, synthesis and evaluation of new L-proline derivatives as acetylcholinesterase inhibitors.
Yun-feng TIAN ; Jun-tao CHEN ; Jun-jie LI ; Ying-chao ZHANG ; Ting-ting CAO ; Zheng-yue MA
Acta Pharmaceutica Sinica 2015;50(6):719-724
In this paper, fourteen new L-proline derivatives were designed and synthesized, and their acetlcholinesterase (AChE) inhibitory activities were also investigated in vitro. New L-proline derivatives were prepared from substituted 2-bromo-1-acetophenones through four-step reaction; and their bioactivities as AChE inhibitors were measured by Ellman spectrophotometry. The results showed that the target compounds had a certain AChE inhibitory activity to in vitro. The bioactivity of compound 8b was the best of them, and its IC50 value was 5.45 µmol.L-1, which was better than that of rivastigmine. So the acetylcholinesterase inhibitory activities of new L-proline derivatives were worth to be further studied.
Acetylcholinesterase
;
Cholinesterase Inhibitors
;
chemical synthesis
;
chemistry
;
Drug Design
;
Proline
;
analogs & derivatives
;
Rivastigmine
;
chemistry
;
Structure-Activity Relationship
10.Design, synthesis and evaluation of 5-aminobenzimidazolone derivatives as acetylcholinesterase inhibitors.
Zheng-yue MA ; Jun-jie LI ; Jun-tao CHEN ; Yun-feng TIAN ; Ying-chao ZHANG ; Yu-qing CAO
Acta Pharmaceutica Sinica 2015;50(1):64-69
The target compounds were prepared from 5-aminobenzimidazolone by two steps reaction, and their AChE inhibitory activities were measured by Ellman method in vitro. The AChE inhibitory activity of compound 4d is the best of them, and its IC50 value is equal to 7.2 μmol·L(-1), which is better than that of rivastigmine; moreover the 4d had no inhibitory activities to BuChE. Therefore, the inhibitory activities of 5-aminobenzimidazolone derivatives to acetylcholinesterase are worth further researching.
Acetylcholinesterase
;
metabolism
;
Benzimidazoles
;
chemical synthesis
;
chemistry
;
Cholinesterase Inhibitors
;
chemical synthesis
;
chemistry
;
Drug Design
;
Phenylcarbamates
;
chemistry
;
Rivastigmine
;
Structure-Activity Relationship